Expert guidance on when to screen, monitor, and initiate complement inhibition therapy in patients without classical PNH

Authors:

Abstract
No abstract available
Funding Information
  • Novartis Pharmaceuticals Corporation
  • Novartis

This publication has 49 references indexed in Scilit: